REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Senhwa Biosciences, Inc. (Taiwan, China)

Main Activities: Pharmaceutical and Medicine Manufacturing | Research and Development in the Physical, Engineering, and Life Sciences
Full name: Senhwa Biosciences, Inc. Profile Updated: February 22, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

Senhwa Biosciences, Inc. mainly engaged in research&development and clinical research of new anti-cancer drugs. The company was founded in 2012 and located in New Taipei City.

Headquarters
10F., No. 225, Sec. 3, Peihsin Rd, Hsintien Dist
New Taipei City; New Taipei City;

Contact Details: Purchase the Senhwa Biosciences, Inc. report to view the information.

Website: http://www.senhwabio.com

Basic Information
Total Employees:
Purchase the Senhwa Biosciences, Inc. report to view the information.
Outstanding Shares:
Purchase the Senhwa Biosciences, Inc. report to view the information.
Financial Auditors:
Purchase the Senhwa Biosciences, Inc. report to view the information.
Incorporation Date:
November 16, 2012
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Chief Financial Officer
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
4.89%
Purchase this report to view the information.
2.03%
Purchase this report to view the information.
1.39%
Purchase this report to view the information.
Purchase this report to view the information.
Subsidiaries
Senhwa Biosciences Corporation (United States)
100%
Company Performance
Financial values in the chart are available after Senhwa Biosciences, Inc. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TWD. Absolute financial data is included in the purchased report.
Net sales revenue
0%
Total operating revenue
157.2%▲
Operating profit (EBIT)
7.41%▲
EBITDA
-0.94%▼
Net Profit (Loss) for the Period
3.47%▲
Total assets
-18.59%▼
Total equity
-19.58%▼
Operating Profit Margin (ROS)
2157.2%▲
Net Profit Margin
953.6%▲
Return on Equity (ROE)
-1.86%▼
Quick Ratio
-31.11%▼
Cash Ratio
-30.92%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo